Log In
Print this Print this

Inhaled Lipid-complexed Cisplatin (ILC)

Also known as: Inhaled Lipid Cisplatin (ILC)

  Manage Alerts
Collapse Summary General Information
Company Eleison Pharmaceuticals Inc.
DescriptionInhaled formulation of cisplatin
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationBone cancer
Indication DetailsTreat pulmonary recurrent osteosarcoma
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today